What is Lenisna?
LENISNA is an exceptional filler with a time-acting formula that combines PDLLA (Poly D, L Lactide) polylactic acid and non-cross-linked hyaluronic acid (HA). It treats deep wrinkles, laxity, and tissue defects with 170 mg of PDLLA polylactic acid and 30 mg of non-cross-linked HA. LENISNA’s particle size ranges from 50 to 60 micrometres, suitable for subcutaneous or periosteal application.
The treatment process involves mixing LENISNA with sterile water and numbing the treatment area if using a cannula. The specialist then administers the treatment using a needle or cannula. LENISNA’s unique formulation allows for immediate filling with HA, while PDLLA microparticles provide support and prevent HA hydrogel from migrating. Over time, PDLLA stimulates collagen production, enhancing skin elasticity and maintaining the treatment’s natural effects.
What makes Lenisna special?
- Hybrid Formula: It combines PDLLA with HA, providing immediate filling effects and long-term collagen stimulation, resulting in natural-looking results.
- Collagen Stimulation: LENISNA effectively stimulates collagen production, improving skin elasticity and restoring a youthful appearance.
- Round Shape of PDLLA Molecules: LENISNA’s PDLLA molecules have a round shape, eliminating the need for post-treatment massage and ensuring a smoother experience for patients.
- Durability of Effects: LENISNA’s effects can last over 24 months, and a single reminder treatment after this period helps sustain the results.
- FDA and CE Certifications: LENISNA is FDA and CE certified, ensuring its safety and effectiveness for cosmetic procedures.
- Patents and Clinical Trials: LENISNA has undergone extensive clinical trials and holds patents, further validating its unique formulation and effectiveness. 7. Particle Size: LENISNA’s particle size allows for easy injection and minimizes the risk of needle clogging, ensuring patient comfort.
- In summary, LENISNA’s hybrid formula, collagen-stimulating properties, durability, round PDLLA molecules, certifications, patents, and particle size make it an innovative and effective solution for deep wrinkles, laxity, and tissue defects.
Overall, LENISNA provides a unique and comprehensive option for skin rejuvenation, backed by clinical evidence, safety certifications, and patented technology.
How many treatments will I need?
The recommended number of treatments typically ranges from 2 to 3, depending on the severity of the skin deficiency, with intervals of 6-8 weeks between treatments. After two years, it is recommended to undergo a single reminder treatment to help maintain the results. This treatment schedule helps ensure that the effects of Lenisma are maximized and sustained over an extended period of time.
It’s important to consult with a qualified healthcare professional who is trained in administering Lenisma to determine the most appropriate treatment plan for your individual needs and to ensure safe and effective results.
It’s important to note that the administration of Lenisma should be performed by a qualified healthcare professional who is trained in the appropriate injection techniques to ensure safe and effective results. The specific injection technique and dosage may vary depending on the individual patient’s needs and the desired outcome and should be determined by the healthcare professional based on a thorough evaluation and consultation with the patient.
Frequently asked questions about Lenisma
The treatment process may involve some discomfort, but it is typically well-tolerated. Prior to the procedure, the treatment area can be numbed with a local anaesthetic to minimize any potential pain or discomfort.
The effects of LENISNA can last over 24 months from the last treatment. However, individual results may vary depending on factors such as lifestyle, metabolism, and the treated area. Follow-up treatment after this period can help maintain and prolong the results.
LENISNA combines PDLLA (Poly D, L Lactide) polylactic acid with non-cross-linked hyaluronic acid (HA). While the ingredients are synthetic, hyaluronic acid is naturally occurring in the body. The treatment aims to stimulate collagen production, which is a natural process in the skin.
LENISNA is considered safe when administered by a trained and qualified medical professional. It has undergone clinical trials and holds FDA and CE certifications, indicating its safety and compliance with regulatory standards. However, as with any medical procedure, there can be potential risks and side effects, which should be discussed with the specialist beforehand.